Press Release
Statement regarding the patent dispute between Cocrystal Technology and KANEKA Corporation in the United States
JIAXING, China, Jan. 2, 2025 /PRNewswire/ — Cocrystal Technology Co., Ltd. ("Cocrystal"), a pioneer of applying drug cocrystal technology in nutritional solutions, has been named in a lawsuit filed by Kaneka Corporation in the United States District Court for the Eastern District of New York (Case Number:1:23-cv-07483-APR-SJB), alleging infringement of U.S. Patent No. 7,829,080 (the "080 Patent"). This lawsuit centers on Cocrystal’s innovative product, Crystal QH®, a premium reduced coenzyme Q10 supplement.
Cocrystal is dedicated to advancing health and wellness through innovative cocrystal technology. Beyond its flagship product, Crystal QH®, Cocrystal has developed a variety of active ingredients with significantly improved stability and bioavailability for the dietary supplement applications.
Cocrystal is vigorously pursuing the invalidity of claims under the 080 Patent, and is confident in a favorable outcome. In the lawsuit, Cocrystal asserts that the claims associated with the 080 Patent are deficient in novelty, creativity, and adequate disclosure. The patent claims patent rights over the presence of any amount of reduced coenzyme Q11 within reduced coenzyme Q10, despite Q11 being a naturally occurring impurity in Q10, as documented in USP standard and various research publications.
Cocrystal is fully committed to defending its legitimate rights and ensuring that the ongoing lawsuit will not impact the market sales of Crystal QH® in United States and any other markets, and that any customers and partners are not adversely affected by this legal challenge.
The information provided in this article was created by Cision PR Newswire, our news partner. The author's opinions and the content shared on this page are their own and may not necessarily represent the perspectives of ThailandChina.
Corporate
Will you still have an office in the post Covid-19 world?
Businesses waste vast resources paying leases for real estate they simply don’t need. Flexible working spaces are a vital way of ensuring that no longer happens.
HONG KONG – (ACN Newswire) – While the pandemic has led many to believe remote work will become the norm, concerns about lagging creativity and loneliness show that there is still a role for the office in a post Covid-19 world, according to The Executive Centre (TEC).
(more…)Markets
Tiger Trade Launches SGX Trading, Meeting Demand from Asian Investors
Access to the Singapore Exchange (SGX) adds to Tiger Brokers’ current menu of stock exchanges, such as the New York Stock Exchange (NYSE) and the Nasdaq Stock Market (NASDAQ), the world’s two largest stock exchanges, as well as the Hong Kong Stock Exchange (HKEX).
SINGAPORE (ACN Newswire) – Tiger Trade, a one-stop mobile and online trading application by Tiger Brokers, has launched access to the Singapore Exchange (SGX).
(more…)Health
APRIL International Care opens up TeleHEALTH service to address Coronavirus worries
The TeleHEALTH service means policyholders do not have to leave their home or workplace to “see” a doctor, with a consultation happening directly over the phone
Hong Kong February 10, 2020 – APRIL International Care has opened up its TeleHEALTH service to all individual and group clients across its Asian region to provide support for clients during the current Coronavirus outbreak.
(more…)- Tesla Sales Slow Down as China’s BYD Gains Ground
- Latest Adjustments to Import-Export Tariffs in China for 2025
- How authoritarian regimes are targeting critics abroad
- China’s Opportunity to Lead on Climate Change in the Wake of Trump’s Withdrawal
- China-linked Hackers Compromised US Treasury Workstations | CNN Business
- Introducing Our 2025 Guide to Corporate Taxation and Compliance in China – Now Available!
